JM
Jonathan Michael Edmund Mahoney
About Jonathan Michael Edmund Mahoney
Data last updated:
Jonathan Michael Edmund Mahoney has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Biocomposites India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Biocomposites India Private Limited at ₹25.77 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Sep 2019 | 2019 | ₹25.77 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jonathan Michael Edmund Mahoney
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jonathan Michael Edmund Mahoney
Jonathan Michael Edmund Mahoney has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Biocomposites India Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Biocomposites India Private Limited at ₹25.77 Cr (FY 2024).
Jonathan Michael Edmund Mahoney is associated with 1 company as Director, including Biocomposites India Private Limited (₹25.77 Cr).
Jonathan Michael Edmund Mahoney has expertise in General Business.
Jonathan Michael Edmund Mahoney has 7 years in corporate governance.
By reported revenue, the largest current company of Jonathan Michael Edmund Mahoney is Biocomposites India Private Limited, with revenue of ₹25.77 Cr (FY 2024).
Jonathan Michael Edmund Mahoney currently holds positions at 1 company: Biocomposites India Private Limited (₹25.77 Cr).